FierceBiotech· @FierceBiotech · X·· 14 天前AI 评分22
AI 导读
在完成一系列交易后，吉利德CEO Daniel O'Day告诉Fierce，未来任何并购活动都将仅用于补充现有战略。https://www.fiercebiotech.com/biotech/its-cancer-and-inflammation-expansion-critical-mass-gileads-oday-eyes-companys-next-chapter @GileadSciences
正文
After a run of dealmaking, Gilead CEO Daniel O'Day told Fierce that any future M&A activity will only be done to complement the existing strategy. https://www.fiercebiotech.com/biotech/its-cancer-and-inflammation-expansion-critical-mass-gileads-oday-eyes-companys-next-chapter @GileadSciences
来源：FierceBiotech · x.com